Table I.
Controls | Autosomal MLH1 foci per cell | % cells with an autosomal bivalent containing 0 MLH1 | % cells with 0 MLH1 foci in the sex body | |
---|---|---|---|---|
Mean | Range | |||
1 | 53.2 | 37–62 | 5 | 10.0 |
2 | 49.2 | 32–60 | 4 | 9.0 |
3 | 49.9 | 33–61 | 7 | 20.0 |
4 | 49.9 | 40–60 | 6 | 10.0 |
5 | 50.7 | 38–59 | 2 | 15.0 |
6 | 51.5 | 37–63 | 1 | 19.0 |
Mean | 50.7 | 32–63 | 4.2 | 13.8 |
NOA | Autosomal MLH1 foci per cell | % cells with an autosomal bivalent containing 0 MLH1 | % cells with 0 MLH1 foci in the sex body | |
Mean | Range | |||
7 | 45.2 | 20–54 | 23 | 14.9 |
8 | 48.9 | 23–61 | 7 | 23.0 |
9 | 42.7 | 15–61 | 16 | 38.0 |
10 | 55.7 | 44–65 | 0 | 3.0 |
11 | 45.0 | 12–57 | 18 | 21.0 |
12 | 48.4 | 27–62 | 18 | 37.0 |
13 | 53.2 | 25–67 | 3 | 18.2 |
Mean | 48.4 | 12–67 | 12.4* | 22.3 |
One hundred pachytene stage spermatocytes were analyzed for all control donors and for 5 NOA patients; 87 and 99 pachytene stage spermatocytes were analyzed for NOA patients 7 and 13, respectively.
*P = 0.024 compared with controls.